During the past decade, Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa) conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Kissei Pharmaceutical Co., Ltd." with 2 trials sponsored, "Peregrine Pharmaceuticals" with 2 trials sponsored and "Rigel Pharmaceuticals" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" are "Depressive Disorder, Major" (3 trials), "Breast Cancer" (2 trials), "Endometriosis" (2 trials), "Non-small-cell Lung Cancer" (2 trials) and "Warm Antibody Autoimmune Hemolytic Anemia" (2 trials). Many other conditions were trialed in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" in a lesser frequency.

Most popular intervention types in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" are "Drug" (18 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa), 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".